Trump administration seeks 10% production cut for 6 opioids
(By Harrison Cook for Becker’s Hospital Review) The U.S. Drug Enforcement Administration and Justice Department on Aug. 16 for U.S. drugmakers
Read More
Woman’s parents fund $95K cancer treatment after UnitedHealthcare denies coverage: 6 things to know
(By Kelly Gooch for Becker’s Hospital Review) UnitedHealthcare denied a cervical cancer patient coverage for life-saving proton beam therapy, reports CNN.
Read MorePurdue Pharma’s Sales Pitch Downplayed Risks Of Opioid Addiction
(By Fred Schulte for Kaiser Health News) Two decades ago, Purdue Pharma produced thousands of brochures and videos that urged
Read MoreHospitals Battle For Control Over Fast-Growing Heart-Valve Procedure
(By Phil Galewitz for Kaiser Health News) BALTIMORE — When Medicare in 2011 agreed to pay for a revolutionary procedure
Read MoreCan artificial intelligence transform health care?
Can artificial intelligence (AI) transform health care as we know it? Some doctors worry that those in the tech world
Read MoreBest Buy expands work in senior healthcare with $800M GreatCall acquisition
(By Julie Spitzer for Becker’s Hospital Review) Best Buy signed a definitive agreement to purchase GreatCall, a provider of connected health and
Read MoreDon’t Be Misled by False Medicare or Social Security Ads
(Source – blog.ssa.gov) Online and otherwise, there’s a lot of information out there, and sometimes it’s difficult to tell what
Read More72K Americans died from opioid overdoses in 2017, CDC estimates
(By Harrison Cook for Becker’s Hospital Review) Fatal opioid overdoses killed more Americans than HIV, car crashes or guns in
Read MoreThese ten Medicare Advantage health plans exceeded industry standards
Medicare Advantage plans are growing in popularity as seniors seek comprehensive coverage for acute and chronic care needs. The attached
Read MoreFDA approves the first generic version of EpiPen
(By Ike Swetlitz for STAT) WASHINGTON — The Food and Drug Administration approved the first-ever generic version of EpiPen Thursday — a
Read More